1-1 of 1
Authors: Anubhav Mathur
Journal Article
Safety and efficacy of filgotinib, lanraplenib and tirabrutinib in Sjögren’s syndrome: a randomized, phase 2, double-blind, placebo-controlled study Open Access
Rheumatology, Volume 61, Issue 12, December 2022, Pages 4797–4808, https://doi.org/10.1093/rheumatology/keac167
Published: 04 April 2022
